Health Care Transition of Adolescents and Young Adults with Haemophilia: the Situation in Germany and the Munich experience.

Abstract:

:Patients suffering from haemophilia encounter various phases in life, in which individual needs, life situations, and self- and disease perception change rapidly. One of these phases spans from the beginning of puberty until early adulthood, in which individuals gain self-responsibility and reach independence and autonomy. In this challenging time that determines future health, adolescents and young adults need sustainable familiar and professional support. A change in health care team and treatment centre may expose adolescent patients to threats but also provides the possible opportunity to be well prepared. While there is emerging evidence that the so-called health care transition programmes are effective in maintaining quality of care in other disease areas, transition programmes for patients with haemophilia are still rare in Germany, and the evidence is limited. We describe the situation in Germany, discuss our experience in Munich and review some of the available guidance; we conclude that transition programmes should become a standard of care in haemophilia. :Patienten mit Hämophilie durchlaufen verschiedene Lebensabschnitte, in denen sich ihre Bedürfnisse, Lebensumstände und ihr Blick auf die Erkrankung und sich selbst verändern. Eine dieser Phasen umfasst die Pubertät und den Übergang ins Erwachsenenalter. In dieser Zeit erlangen die Patienten Eigenverantwortung und streben nach Unabhängigkeit und Autonomie. Diese Phase ist herausfordernd und bestimmend für die gesundheitliche Zukunft. Daher benötigen die Patienten eine tragfähige familiäre und professionelle Unterstützung, um Ängsten zu begegnen und mögliche Chancen herauszuarbeiten. Die Effektivität von Transitions-Programmen wird bereits für viele Krankheitsbilder in der Literatur beschrieben, allerdings werden diese im Bereich der Hämophilie in Deutschland selten angewendet. Wir beschreiben die Situation in Deutschland, erläutern unsere Münchner Erfahrungen und besprechen einige der verfügbaren Empfehlungen aus der Literatur. Zusammenfassend sollten Transitions-Program Teil der Routinebehandlung bei Hämophilie werden.

journal_name

Hamostaseologie

journal_title

Hamostaseologie

authors

Bidlingmaier C,Olivieri M,Schilling FH,Kurnik K,Pekrul I

doi

10.1055/s-0039-3402804

subject

Has Abstract

pub_date

2020-02-01 00:00:00

pages

97-104

issue

1

eissn

0720-9355

issn

2567-5761

journal_volume

40

pub_type

杂志文章,评审
  • [Upper ankle joint prostheses in haemophilia patients].

    abstract:UNLABELLED:Secondary arthrosis of the upper ankle joint (talocalcanean joint) is one of the most frequent forms of haemophilic arthropathy. It is a secondary form of arthrosis not only because of chronic synovitis and cartilage injury resulting from chronic recurrent intraarticular bleeds, but also due to the misalignm...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Berdel P,Schott D,Pagenstert G,Pennekamp P,Oldenburg J,Wirtz DC,Seuser A,Gravius S

    更新日期:2009-10-01 00:00:00

  • Subchondral haematoma.

    abstract::Haemophilic arthropathy is a complex multifactorial disorder that poses significant challenges to both the treating haematologist and arthroplasty surgeon. Its pathogenesis is incompletely understood. Recent literature has concentrated on the toxic effects of iron and the characteristic inflammatory synovitis. Discuss...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-15-12-0033

    authors: Wharton R,Austin S,Back D

    更新日期:2017-01-01 00:00:00

  • Clot waveform analysis in patients with haemophilia A.

    abstract:UNLABELLED:Clot waveform analysis extends the interpretation of aPTT measurement curves. The curve is mathematically processed to obtain information about fibrin formation kinetics including semiquantitative determination of thrombin, prothrombinase and tenase activity. PATIENTS, METHOD:In this study the feasibility o...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-02-0016

    authors: Siegemund T,Scholz U,Schobess R,Siegemund A

    更新日期:2014-01-01 00:00:00

  • Thrombin generation and venous thromboembolism.

    abstract::Venous thromboembolism is a chronic and potential fatal disease. Determination of recurrence risk is time-consuming and costly, and sometimes not feasible: many patients carry more than one risk factor, the relevance of some factors with regard to risk of recurrence is unknown, and existence of thus far unknown risk f...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Eichinger S

    更新日期:2008-02-01 00:00:00

  • Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis.

    abstract:UNLABELLED:Atherosclerosis is a chronic inflammatory disease of the vascular wall that results from disturbed lipoprotein metabolism and increased oxidative stress. A major consequence of this is lipid peroxidation, which generates a number of breakdown products of membrane lipids that form so called oxidation-specific...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0069

    authors: Bartolini Gritti B,Binder CJ

    更新日期:2016-05-10 00:00:00

  • [Inhibitor development after changing FVIII/IX products in patients with haemophilia].

    abstract:UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kocher S,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2012-01-01 00:00:00

  • Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapy.

    abstract::The translation of fundamental science-based constructs to the preemptive identification and optimal management of individuals with or those at risk for thrombotic disorders of the cardiovascular system has taken a step closer to being realized with the development of molecular technologies that include nucleic acid a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Becker RC,Oney S,Becker KC,Rusconi CP,Sullenger B

    更新日期:2007-12-01 00:00:00

  • [Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa].

    abstract::Replacement therapy of coagulation factor preparations (AT, FFP, PPSB, FXIII, rFVIIa) are frequently used on the Intensive Care Units. Indications, dosage, specific effects and side effects have to be considered. ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hämo05020209

    authors: Scharrer I

    更新日期:2005-05-01 00:00:00

  • Thrombophilia and its impact on pregnancy.

    abstract:UNLABELLED:In recent years thrombophilia has gained much attention as a risk factor for pregnancy complications. Whereas there is an established correlation between antiphospholipid-antibodies and pregnancy loss, data for other risk factors of thrombosis are less well established. Data suggest associations with antithr...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Pabinger I

    更新日期:2008-01-01 00:00:00

  • [Monitoring of anticoagulants of secondary haemostasis].

    abstract::Vitamin K-antagonists and heparin belong to the established indirect acting anticoagulants. For many years these drugs were the only possibility for prophylaxis and treatment of venous and arterial thrombosis. The challenges for the routine laboratory related to the treatment with vitamin K-antagonists and heparin can...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Schuster B

    更新日期:2009-08-01 00:00:00

  • [Pathophysiology of acute coronary syndrome].

    abstract::This article reviews the current understanding of the pathophysiology of acute coronary syndrome and how these concepts have altered our clinical approach to the acute phase of coronary heart disease. Thrombosis due to erosion or, in most cases, rupture of a vulnerable atherosclerotic plaque underlies most acute coron...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Hölschermann H,Tillmanns H,Bode C

    更新日期:2006-05-01 00:00:00

  • [Antithrombotic therapy of acute coronary syndromes].

    abstract::Recent advances in the diagnosis and the treatment of acute coronary syndromes (ACS) have led to a substantial reduction of major coronary events, to an improvement in patient outcome and the definition of new guidelines. Current strategies for the treatment of patients with non-ST-elevation ACS recommend a combined a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Hölschermann H

    更新日期:2007-12-01 00:00:00

  • Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models.

    abstract::Nutrient excess in obesity drives metabolic reprogramming in multiple tissues involving extensive interorgan and intercellular crosstalk. Experimental and clinical studies show that prolonged nutrient excess often compromises metabolic adaptation propagating proobesogenic and proinflammatory responses. Chronic inflamm...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1688800

    authors: Madhusudhan T,Ruf W

    更新日期:2019-06-01 00:00:00

  • The vulnerable myocardium. Diabetic cardiomyopathy.

    abstract::Cardiovascular disease is the major cause of morbidity and mortality in subjects suffering from diabetes mellitus. While coronary artery disease is the leading cause of cardiac complications in diabetics, it is widely recognized that diabetes increases the risk for the development of heart failure independently of cor...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-09-0038

    authors: Bugger H,Bode C

    更新日期:2015-01-01 00:00:00

  • Complement activation in thrombotic microangiopathy.

    abstract::The endothelium lining the vascular lumen is continuously exposed to complement from the circulation. When erroneously activated on host cells, complement may generate a deleterious effect on the vascular wall leading to endothelial injury, exposure of the subendothelial matrix and platelet activation. In this review ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-12-12-0025

    authors: Karpman D,Tati R

    更新日期:2013-05-29 00:00:00

  • Old and new anticoagulants.

    abstract::Vitamin-K-antagonists (VKA) and heparins have been complementary anticoagulants for prevention and treatment of thrombosis for almost 70 years. In contrast to heparins, VKA have not been modified pharmacologically, however treatment surveillance has improved by introducing INR and self-monitoring/management. Disclosur...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1149

    authors: Harbrecht U

    更新日期:2011-02-01 00:00:00

  • Phenotypic approaches to gene mapping in platelet function disorders - identification of new variant of P2Y12, TxA2 and GPVI receptors.

    abstract::Platelet number or function disorders cause a range of bleeding symptoms from mild to severe. Patients with platelet dysfunction but normal platelet number are the most prevalent and typically have mild bleeding symptoms. The study of this group of patients is particularly difficult because of the lack of a gold-stand...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Watson S,Daly M,Dawood B,Gissen P,Makris M,Mundell S,Wilde J,Mumford A

    更新日期:2010-01-01 00:00:00

  • How I Manage Thrombotic/Thromboembolic Complications in Myeloproliferative Neoplasms.

    abstract::Patients with myeloproliferative neoplasms (MPNs), such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis, are at increased risk for arterial and venous thrombosis/thromboembolism. In particular, the risk of splanchnic venous thrombosis, such as portal vein thrombosis or Budd-Chiari syndrome, ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0040-1701474

    authors: Koschmieder S

    更新日期:2020-02-01 00:00:00

  • Platelet monitoring for PCI: is it really necessary?

    abstract::Percutaneous coronary intervention (PCI) has significantly improved clinical outcomes in coronary artery disease patients. Since PCI is associated with platelet activation, antiplatelet therapy with aspirin, clopidogrel and GPIIb/IIIa inhibitors comprise the cornerstone strategy during and following PCI. The latter ag...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Tantry US,Gurbel PA

    更新日期:2009-11-01 00:00:00

  • Use of recombinant factor VIIa in the perioperative period.

    abstract::Recombinant activated factor VII (rFVIIa) is a pro-haemostatic agent that can be used for patients with haemophilia and inhibiting antibodies towards a coagulation factor. Recombinant factor VIIa is, however, increasingly used for several other indications, including patients who experience serious and life-threatenin...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Levi M

    更新日期:2009-01-01 00:00:00

  • Vitamin K antagonists. Ready to be replaced?

    abstract::For the last decades, anticoagulation for stroke prevention in atrial fibrillation (AF) as well as for the prophylaxis and long-term treatment of venous thromboembolism has been entirely based on vitamin K antagonists (VKA). Although very effective under optimal conditions, long-term treatment with these drugs is flaw...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-12050008

    authors: Steffel J,Luscher TF

    更新日期:2012-01-01 00:00:00

  • Orthopedic approach of haemophiliacs. A single center experience in Romania.

    abstract:UNLABELLED:Clinical expression of inadequately treated haemophilia is dominated by orthopedic complications, requiring invasive or non-invasive interventions. OBJECTIVE:In Romania, with under dosed and late introduced "on demand" substitution, we aimed at highlighting the experience of orthopedic treatment and its out...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Serban M,Mihailov MD,Poenaru D,Pop L,Branea I,Bataneant M,Lăcătuşu A,Barna L,Tepeneu N,Schramm W

    更新日期:2008-10-01 00:00:00

  • [Primary and secondary prevention of the acute coronary syndrome].

    abstract::Coronary heart disease and the acute coronary syndrome are the leading causes of death in Germany. In prospective observational studies conventional risk factors such as smoking, arterial hypertension, hypercholesterolaemia, and diabetes can explain over 80% of cardiovascular diseases. Therefore, cardiovascular diseas...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Weingärtner O,Laufs U

    更新日期:2006-05-01 00:00:00

  • VKCFD2 - from clinical phenotype to molecular mechanism.

    abstract::Vitamin K 2,3-epoxide reductase complex, subunit 1 (VKORC1) is an enzyme essential for the vitamin K cycle. VKORC1 catalyses the reduction of vitamin K 2,3-epoxide to the quinone form of vitamin K and further to vitamin K hydroquinone. The generated vitamin K hydroquinone serves as substrate for the enzyme γ-glutamyl-...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Czogalla KJ,Watzka M,Oldenburg J

    更新日期:2016-11-08 00:00:00

  • Diagnosis and treatment of superficial vein thrombosis.

    abstract::Superficial vein thrombosis (SVT) is a common disease, characterized by an inflammatory-thrombotic process in a superficial vein. Typical clinical findings are pain and a warm, tender, reddish cord along the vein. Until recently, no reliable epidemiological data were available. The incidence is estimated to be higher ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-13-04-0027

    authors: Bauersachs RM

    更新日期:2013-08-01 00:00:00

  • [Platelets: biochemistry and physiology].

    abstract::This article reviews the roles of blood platelets in haemostasis as well as in the pathogenesis of thromboembolic diseases. Besides the basic processes in primary haemostasis, platelet adhesion, platelet secretion, platelet aggregation, clot retraction, the new model of thrombin formation on the platelet surface is pr...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Kehrel BE

    更新日期:2008-12-01 00:00:00

  • Acquired Haemophilia A Associated with Subsequent Hepatocellular Carcinoma.

    abstract::Acquired haemophilia A (AHA) is a rare autoimmune disease caused by antibodies directed against clotting factor VIII. About half of cases are idiopathic, but AHA may also be secondary to autoimmune, dermatologic, or oncologic diseases. In approximately 10% of non-idiopathic cases, the disease occurs after or with the ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1668570

    authors: Pacholczak R,Bazan-Socha S,Zdziarska J,Iwaniec T,Walocha JA,Musiał J,Dropiński J

    更新日期:2019-02-01 00:00:00

  • Understanding and Preventing Placenta-Mediated Pregnancy Complications.

    abstract::Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss. Pathophysiology is complex, and may be linked to prothrombotic disorders such as antiphospholipid syndrome, whose understanding is still evo...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1184-8388

    authors: Skeith L,Blondon M,Ní Áinle F

    更新日期:2020-08-01 00:00:00

  • [Update of INR-selfmonitoring].

    abstract::Nearly every second patient, who needs an oral anticoagulation with vitamin K antagonists, is feasible to perform INR-self-management after participation in a structured teaching program. Patient self-testing or measuring the INR value by relatives or nurses would increase this method of control by the aid of telemedi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Völler H,Braun S

    更新日期:2008-10-01 00:00:00

  • In Vitro Closure Times (PFA-100) Are Different Between Peritoneal Dialysis and Hemodialysis.

    abstract:INTRODUCTION: Platelet dysfunction is not uncommon in patients with end-stage renal disease (ESRD). Type of renal replacement therapy may have an effect on platelet functions, which has not been well investigated. We evaluated in vitro closure time (CT) differences between peritoneal dialysis (PD) and hemodialysis (HD)...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1171-0499

    authors: Gokalp C,Karadag FK,Braunisch MC,Schmaderer C,Gunay E,Kiper HD,Tobu M,Ustün C,Demirci MS,Ozkahya M

    更新日期:2020-12-01 00:00:00